Notice of Change to RFA-DA-21-005, "Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional)"

Notice Number: NOT-DA-20-049

Key Dates
Release Date: April 13, 2020

Related Announcements
RFA-DA-21-005 - Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional)

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of the Notice is to change the application due dates in RFA-DA-21-005 "Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional)".

Currently reads

Open Date (Earliest Submission Date): June 14, 2020

Letter of Intent Due Date(s): June 14, 2020

Application Due Date(s):

July 14, 2020

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

July 14, 2020

All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date: July 15, 2020

Modified to read

Open Date (Earliest Submission Date): July 13, 2020

Letter of Intent Due Date(s): July 13, 2020

Application Due Date(s):

Only accepting applications for the AIDS Application Due Date(s) listed below..

AIDS Application Due Date(s)

August 13, 2020

All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date: August 14, 2020

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Vasundhara Varthakavi, DVM, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-2146
Email: vasundhara.varthakavi@nih.gov

John Satterlee Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1020
Email: satterleej@nida.nih.gov